YTB323, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, TOCILIZUMAB
CYTB323R12101
Phase 2 small_molecule active
Quick answer
YTB323, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, TOCILIZUMAB for Non-active Progressive Multiple Sclerosis (PMS) is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Non-active Progressive Multiple Sclerosis (PMS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active